Comparison of Methimazole and Propylthiouracil in Patients with Hyperthyroidism Caused by Graves’ Disease | Zendy

Hirotoshi Nakamura | Zendy; Jaeduk Yoshimura Noh | Zendy; Koichi Itoh | Zendy; Shuji Fukata | Zendy; Akira Miyauchi | Zendy; Noboru Hamada | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Comparison of Methimazole and Propylthiouracil in Patients with Hyperthyroidism Caused by Graves’ Disease

Author(s) -

Hirotoshi Nakamura,

Jaeduk Yoshimura Noh,

Koichi Itoh,

Shuji Fukata,

Akira Miyauchi,

Noboru Hamada

Publication year - 2007

Publication title -

the journal of clinical endocrinology and metabolism

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.206

H-Index - 353

eISSN - 1945-7197

pISSN - 0021-972X

DOI - 10.1210/jc.2006-2135

Subject(s) - propylthiouracil , medicine , methimazole , graves' disease , context (archaeology) , adverse effect , antithyroid agent , endocrinology , gastroenterology , prospective cohort study , disease , thyroid , paleontology , biology

Although methimazole (MMI) and propylthiouracil (PTU) have long been used to treat hyperthyroidism caused by Graves' disease (GD), there is still no clear conclusion about the choice of drug or appropriate initial doses.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research